Back to Articles
31132026 Q3StandardJGAAP

UNIVA Oak Holdings (3113) FY2026 Q3 Earnings Report

For FY2026 Q3, revenue came to ¥1.3B (-36.3% year on year) and operating loss ¥494.0M. The segment drivers and cash flow follow.

Financials (ex Banks)/Securities & Commodities Futures


Quick View

MetricCurrent PeriodSame Period of Previous YearYoY
Revenue¥1.34B¥2.11B−36.3%
Operating Income−¥0.49B−¥0.46B−8.3%
Ordinary Income−¥0.41B−¥0.40B−3.2%
Net Income−¥0.42B−¥0.11B−281.9%
ROE (annualized)−37.9%−8.2%-

Executive Summary

For the nine months ended Q3, Revenue declined 36.3% YoY, while the operating loss widened, indicating that business contraction and deteriorating profitability are progressing simultaneously. Revenue was ¥1.34B (¥2.11B in the previous year, △36.3%), Operating Income was ¥△0.49B (¥△0.46B in the previous year), Ordinary Income was ¥△0.41B (¥△0.40B in the previous year), and Net Income was ¥△0.42B (¥△0.11B in the previous year). Significant declines in the Renewable Energy and Beauty & Healthcare businesses, the Company’s core businesses, directly contributed to the widening segment losses, which could not be offset by the turnaround to profitability in the Growth Support Business.

Factors Affecting Results

【Revenue】Revenue decreased 36.3% YoY to ¥1.34B. By segment, the two core businesses recorded significant revenue declines: Renewable Energy generated ¥0.45B (an estimated 41% decline from the previous year), while Beauty & Healthcare generated ¥0.39B (down 59.8%). In contrast, Growth Support generated ¥0.11B (up 53.4% YoY), and Digital Marketing generated ¥0.23B (up 3.3%), maintaining generally flat levels. The newly established Trading Business recorded ¥0.02B and is in the startup phase following the acquisition of a pharmaceutical wholesale license.

【Profit and Loss】Gross profit was ¥0.87B, and the gross margin improved to 64.8% from 60.1% in the same period of the previous year. However, this improvement resulted from the decline in cost of sales (△43.7%) exceeding the decline in Revenue, and therefore reflects the reverse side of the contraction in business scale. SG&A expenses were ¥1.36B, down only 20.9% YoY, causing the SG&A ratio to Revenue to rise to 101.6%. Consequently, the operating loss widened to ¥0.49B, and the operating margin deteriorated from △21.7% in the same period of the previous year to △36.8%. In non-operating items, foreign exchange gains of ¥0.15B contributed to reducing the ordinary loss to ¥0.41B. However, there were no extraordinary gains, including the ¥0.22B gain on the sale of shares in a subsidiary recorded in the same period of the previous year, and Net Income deteriorated from ¥△0.11B in the previous year to ¥△0.42B. This represents a decline in both Revenue and profit, with profitability also deteriorating due to lower absorption of fixed costs.

Segment Analysis

Growth Support was the only profitable segment, with Revenue of ¥0.11B, Operating Income of ¥0.03B, and a profit margin of 27.3%, making it the pillar of profitability within the consolidated group. Renewable Energy recorded an Operating Loss of ¥0.21B against Revenue of ¥0.45B, for a margin of △47.2%, while Beauty & Healthcare recorded an Operating Loss of ¥0.11B against Revenue of ¥0.39B, for a margin of △27.9%. The losses in these two core businesses significantly pressured consolidated earnings. Digital Marketing generated Revenue of ¥0.23B and an Operating Loss of ¥0.01B, for a margin of △6.3%, remaining almost flat. The newly established Trading Business generated Revenue of ¥0.02B and an Operating Loss of ¥0.001B. Adjustments, including corporate expenses, amounted to a loss of ¥0.14B, further reducing consolidated Operating Income in addition to the losses of the reported segments.

Key Financial Indicators

【Profitability】The operating margin deteriorated to △36.8% from △21.7% in the same period of the previous year, while the SG&A ratio remained high at 101.6%, despite the improvement in the gross margin to 64.8% from 60.1%. The Net Income margin was approximately △31.1%, and ROE (annualized) was △37.9%, indicating a continued decline in the return-generating capacity of equity. 【Cash Quality】Cash and deposits were ¥0.67B, down from ¥0.85B in the previous year. Inventories increased approximately 2.9 times YoY to ¥0.30B, while accounts receivable declined to ¥0.31B, suggesting lower working capital efficiency accompanied by inventory accumulation. 【Investment Efficiency】Total assets were ¥4.97B and remained largely flat, but asset turnover relative to Revenue remained low, and the Company has not yet generated returns commensurate with its asset base. 【Financial Soundness】The Equity Ratio declined to 29.5% from 35.6% in the previous year, while net assets decreased 17.9% YoY to ¥1.47B from ¥1.78B. Interest-bearing debt expanded due to increases in short-term and long-term borrowings, and accumulated losses in retained earnings widened to ¥△0.99B.

Cash Flow Analysis

Although detailed disclosures for the statement of cash flows are unavailable, cash trends can be inferred from changes in the balance sheet. Cash and deposits declined to ¥0.67B from ¥0.85B in the previous year. Meanwhile, short-term borrowings increased substantially from ¥0.003B to ¥0.303B, and long-term borrowings rose from ¥0.422B to ¥1.224B, suggesting that borrowings are being used to supplement cash management amid operating losses. Inventories increased from ¥0.103B to ¥0.295B, while accounts receivable declined from ¥0.453B to ¥0.309B and accounts payable declined from ¥0.147B to ¥0.108B, indicating that inventory buildup and the reduction of trade liabilities are exerting pressure on working capital. Overall, the Company appears to have used increased borrowings to offset cash outflows from operating losses, thereby limiting the decline in its cash balance to a certain extent.

Quality of Earnings

The ordinary loss of ¥0.41B was reduced from the operating loss of ¥0.49B by non-operating income, including foreign exchange gains of ¥0.15B, and does not indicate a recovery in the profitability of the core business. Non-operating income included foreign exchange gains of ¥0.15B, meaning that sustainability is limited because it depends on highly volatile market factors. Extraordinary items were almost neutral, comprising extraordinary gains of ¥0.01B and extraordinary losses of ¥0.01B. Extraordinary gains of ¥0.296B, including the ¥0.22B gain on the sale of shares in a subsidiary recorded in the same period of the previous year, were absent in the current period, and the loss of this one-time factor contributed to the YoY deterioration in Net Income. Comprehensive Income was ¥△0.33B, differing from Net Income of ¥△0.42B, primarily due to a positive foreign currency translation adjustment of ¥0.09B. The significant increase in inventories contains future monetization risk, and continued monitoring of inventory valuation and turnover is necessary from an accrual perspective.

Shareholder Returns

The Q2 dividend was ¥0 per share, and there was no interim dividend for the current period. As the quarterly net loss attributable to owners of the parent was ¥0.41B, the Payout Ratio cannot be calculated because there is no applicable profit. With accumulated losses widening to ¥0.99B and interest-bearing debt also increasing, maintaining the financial base should currently take priority over shareholder returns.

Risk Factors

  1. Deteriorating profitability of the two core businesses: Renewable Energy recorded an Operating Loss of ¥0.21B against Revenue of ¥0.45B, while Beauty & Healthcare recorded Revenue of ¥0.39B, down 59.8% YoY, and an Operating Loss of ¥0.11B. Widening losses in both businesses are directly pressuring consolidated profitability.

  2. Increased financial leverage: Short-term borrowings increased from ¥0.003B in the previous year to ¥0.303B, while long-term borrowings increased from ¥0.422B to ¥1.224B. The Equity Ratio declined to 29.5%, and the increased reliance on borrowings amid operating losses is a factor reducing financial flexibility.

  3. Declining working capital efficiency: Inventories increased approximately 2.9 times YoY, while accounts receivable and accounts payable declined, suggesting inventory accumulation and the immobilization of funds. The monetization and valuation of inventories will affect the quality of earnings going forward.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (utilities)

Profitability and Returns

MetricCompanyMedian (IQR)Delta
Operating Margin−36.8%
Net Income Margin−31.1%

The Company recorded substantial losses in both Operating Margin and Net Income Margin. As comparable median data has not been established, its relative position within the industry can only be assessed to a limited extent.

Growth and Capital Efficiency

MetricCompanyMedian (IQR)Delta
Revenue Growth Rate (YoY)−36.3%

The Revenue Growth Rate was substantially negative, indicating a pronounced contraction in business scale. However, comparison with industry levels remains a future issue because median data is unavailable.

※Source: Compiled by the Company

Key Takeaways from the Financial Results

  1. Although the gross margin improved to 64.8%, the SG&A ratio remained high at 101.6%, indicating from the financial results that the fixed-cost structure is the primary factor behind the widening operating loss.

  2. While the Growth Support Business was the only profitable segment, with a profit margin of 27.3%, the core Renewable Energy and Beauty & Healthcare businesses posted substantial losses, indicating a widening profitability disparity within the business portfolio.

  3. The substantial increases in short-term and long-term borrowings and the decline in the Equity Ratio to 29.5% are noteworthy as a change in the financing structure amid continued operating losses.


This report is an earnings analysis document automatically generated by AI based on XBRL financial results summary data. It does not recommend investment in any specific securities. The industry benchmarks are reference information compiled by the Company based on publicly available financial results data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---